Skip to main content
AmigoFish

82: GLP-1s Beyond Weight Loss – The Future of Women’s Health, Fertility, Hormones, and Longevity | SXSW Panel Discussion Featuring McCall McPherson, Natalie Crawford, Jessica Shepherd & Shannon Ritchey

From Modern Thyroid and Wellness · · 1 hr 14 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

What if GLP-1 medications are not just changing weight loss—but completely transforming the future of women’s health?

In this special SXSW panel discussion, Shannon Ritchey moderates an eye-opening conversation with leading experts McCall McPherson, Natalie Crawford, and Jessica Shepherd about the rapidly evolving role of GLP-1 medications in fertility, thyroid health, inflammation, menopause, longevity, metabolic health, and chronic disease prevention.

This conversation goes far beyond weight loss. The panel explores how GLP-1 medications may reduce systemic inflammation, improve insulin resistance, support fertility outcomes, influence hormone health during perimenopause and menopause, protect cardiovascular health, and potentially reshape the future of longevity medicine.

The discussion also tackles common myths, cancer fears, muscle loss concerns, microdosing strategies, fertility safety, lifestyle foundations, and the importance of preserving muscle while using these medications.

🔑 Key Topics Covered

- Why GLP-1 medications are far more than “weight loss drugs”

- How GLP-1s improve insulin sensitivity and metabolic function

- The powerful role GLP-1s may play in reducing systemic inflammation

- Why microdosing GLP-1s is becoming an emerging strategy in medicine

- The truth about thyroid cancer concerns and current research findings

- How under-fueling and poor nutrition contribute to muscle loss on GLP-1s

- Why strength training and protein intake are essential while using GLP-1s

- The connection between inflammation, thyroid disease, and metabolic dysfunction

- How GLP-1s may support fertility in women with PCOS and insulin resistance

- Why GLP-1s should be stopped before pregnancy attempts

- The impact of chronic inflammation on ovarian reserve and fertility outcomes

- How GLP-1s may improve endometriosis symptoms and inflammatory reproductive conditions

- The role of GLP-1s in perimenopause, menopause, and hormonal aging

- Why estrogen decline impacts glucose regulation and inflammation

- The connection between visceral fat, inflammation, and chronic disease

- Emerging research on GLP-1s, addiction behavior, fatty liver disease, and longevity

- Why personalized medicine and lifestyle intervention remain essential

🧠 GLP-1s Are Not Just About Eating Less

One of the strongest themes throughout the panel:

👉 GLP-1 medications are not simply making people lose weight because they eat less.

According to McCall McPherson, these medications fundamentally improve:

- Metabolic function

- Insulin sensitivity

- Inflammatory pathways

- Physiological responses to food

This is especially important for women with:

- Thyroid dysfunction

- PCOS

- Autoimmune disease

- Menopause-related metabolic changes

The panel repeatedly emphasizes:

👉 Weight gain is often not a willpower problem—it is a metabolic and inflammatory problem.

⚡ The Emerging Power of Microdosing

A major topic discussed is microdosing GLP-1s.

What Is Microdosing?

Using:

- Much smaller doses

- More personalized dosing strategies

- Flexible adjustments based on symptoms and goals

Rather than aggressively increasing medication doses, microdosing may help:

- Reduce nausea

- Improve tolerability

- Allow proper fueling and protein intake

- Preserve muscle mass

- Maintain metabolic benefits

McCall McPherson explains that many patients experience:

- Significant inflammation reduction

- Metabolic improvement

- Better energy

…even at very low doses.

🔥 Inflammation: The Hidden Driver of Disease

Throughout the panel, inflammation is described as one of the biggest underlying drivers of:

- Fertility struggles

- Thyroid disease

- Insulin resistance

- Cardiovascular disease

- Joint pain

- Menopausal symptoms

The panelists repeatedly explain that GLP-1s appear to dramatically reduce inflammation—sometimes within days.

Why This Matters

Reducing inflammation may influence:

- Hormonal signaling

- Ovarian function

-…

Back to Modern Thyroid and Wellness · Report a problem